Showing results (71-80 of 123) with videos related to

Sort By:
Pageof 13
ERJ Open Research|October 29, 2025
The response of rare CFTR mutations to specific modulator combinationsNoemie Stanleigh, Michal Gur, Michal Shteinberg, et al.
Respiratory Medicine|September 27, 2017
Ivacaftor for the p.Ser549Arg (S549R) gating mutation - The Israeli experienceAdi Dagan, Malena Cohen-Cymberknoh, Michal Shteinberg, et al.
The European Respiratory Journal|September 10, 2024
Cathepsin C (dipeptidyl peptidase 1) inhibition in adults with bronchiectasis: AIRLEAF, a phase II randomised, double-blind, placebo-controlled, dose-finding studyJames D Chalmers, Michal Shteinberg, Marcus A Mall, et al.
The European Respiratory Journal|February 2, 2018
The independent contribution of <i>Pseudomonas aeruginosa</i> infection to long-term clinical outcomes in bronchiectasisDavid Araújo, Michal Shteinberg, Stefano Aliberti, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 5, 2016
Eradication failure of newly acquired Pseudomonas aeruginosa isolates in cystic fibrosisMalena Cohen-Cymberknoh, Noa Gilead, Silvia Gartner, et al.
American Journal of Respiratory and Critical Care Medicine|January 23, 2018
Characterization of the "Frequent Exacerbator Phenotype" in BronchiectasisJames D Chalmers, Stefano Aliberti, Anna Filonenko, et al.
American Journal of Respiratory and Critical Care Medicine|September 28, 2023
Inflammatory Molecular Endotypes in Bronchiectasis: A European Multicenter Cohort StudyHayoung Choi, Soorack Ryu, Holly R Keir, et al.
Pageof 13